Valeant, Ackman Ink Allergan Litigation Management Deal
By Melissa Daniels ( February 13, 2017, 9:23 PM EST) -- Valeant Pharmaceuticals International Inc. and William Ackman's hedge fund Pershing Square Capital Management have agreed to split litigation costs in a putative class action over an alleged insider trading scheme in 2014's Allergan takeover bid, according to a filing made Monday with the U.S. Securities and Exchange Commission....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.